Dr. Reddy’s Laboratories Ltd ADR (RDY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
10,204,111,000
EV to revenue ratio (TTM)
3.015
EV to ebitda
14.98
Financial Performance
Revenue (TTM)
331,186,012,000
Gross profit (TTM)
166,176,997,000
EBITDA
54,671,999,000
Profitability
Operating margin (TTM)
4.25%
Profit margin
10.00%
Return on assets (TTM)
4.01%
Return on equity (TTM)
8.84%
Per Share Metrics
Revenue per share (TTM)
66.41
EPS
0.41
Diluted EPS (TTM)
0.41
Book value
0.81
Dividend per share
8
Dividend yield
0.68%
Valuation Multiples
P/E ratio
29.88
Trailing P/E
29.88
Forward P/E
27.03
PEG ratio
1.649
Price to sales ratio (TTM)
0.031
Price to book ratio (TTM)
2.576
Growth
Quarterly earnings growth (YoY)
-5.60%
Quarterly revenue growth (YoY)
-68.70%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
2
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.242